Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Supernus Pharmaceuticals Inc | SUPN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 29.31 | 08:29:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 29.31 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 21.99 - 38.09 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 29.31 | USD |
Supernus Pharmaceuticals (SUPN) Options Flow Summary
Supernus Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.6B | 54.73M | - | 609.04M | 1.32M | 0.02 | 1,221.25 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Supernus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SUPN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 28.67 | 31.84 | 28.67 | 29.65 | 292,900 | 0.64 | 2.23% |
| 1 Month | 34.10 | 34.49 | 28.63 | 30.98 | 344,545 | -4.79 | -14.05% |
| 3 Months | 27.52 | 35.44 | 26.2733 | 31.29 | 396,087 | 1.79 | 6.50% |
| 6 Months | 23.39 | 35.44 | 21.99 | 29.06 | 383,541 | 5.92 | 25.31% |
| 1 Year | 37.16 | 38.09 | 21.99 | 30.12 | 416,433 | -7.85 | -21.12% |
| 3 Years | 31.43 | 42.09 | 21.99 | 31.26 | 416,130 | -2.12 | -6.75% |
| 5 Years | 36.63 | 42.09 | 13.12 | 28.17 | 476,526 | -7.32 | -19.98% |
Supernus Pharmaceuticals Description
| Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others. |
